Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 12-2021 | 03-2021 | |
| Sales | 85,671 | 80,820 | 100,005 | 0 | 0 |
| Cost of Goods | 15,014 | 16,588 | 22,318 | N/A | 0 |
| Gross Profit | 70,657 | 64,233 | 77,687 | N/A | 0 |
| Operating Expenses | 82,692 | 127,658 | 98,288 | 549 | 549 |
| Operating Income | -12,021 | -62,838 | -20,284 | -549 | -549 |
| Interest Expense | 2,193 | 6,250 | 4,491 | 0 | 0 |
| Other Income | 154 | 4,931 | 3,768 | 4 | 0 |
| Pre-tax Income | -14,061 | -64,157 | -21,006 | -546 | -549 |
| Income Tax | -132 | -3,063 | 165 | N/A | 0 |
| Net Income Continuous | -13,929 | -61,094 | -21,171 | -546 | -549 |
| Net Income | $-13,929 | $-61,094 | $-21,171 | $-546 | $-546 |
| EPS Basic Total Ops | -0.73 | -5.70 | -2.30 | -0.30 | N/A |
| EPS Basic Continuous Ops | -0.73 | -5.71 | -2.28 | -0.95 | N/A |
| EPS Diluted Total Ops | -0.73 | -5.70 | -2.30 | -0.30 | N/A |
| EPS Diluted Continuous Ops | -0.73 | -5.71 | -2.28 | -0.95 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.39 | -5.70 | N/A | N/A | N/A |
| EBITDA(a) | $-6,915 | $-56,892 | $-14,945 | $-549 | $-549 |